Dabrafenib alters MDSC differentiation and function by activation of GCN2 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AR067763-06
Mechanistic relationships between IDO, GCN2, and mTOR signals in immunity to apoptotic cells
National Institutes of Health
Grant: 1R21AI105500-01A1
The role of GCN2-kinase in antigen presenting cell function and tolerance to self
National Institutes of Health
Grant: 5R01CA190449-06
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
Fields of Study
Keywords
Sustainable Development Goals